Mechanisms of airway smooth muscle contraction : physio-pharmacologic factors and intracellular signaling pathway

气道平滑肌收缩机制:生理药理学因素和细胞内信号通路

基本信息

项目摘要

This study was carried out to determine the effects of Rho-kinase inhibitors, Y-27632 and fasudil, on the anticholinesterase (anti-ChE)-induced contractile and phosphatidylinositol responses of rat trachea. In vitro measurements of isometric tension and [^3H] inositol monophosphate (IP_1) formed were conducted by using rat tracheal rings or slices. Neostigmine- and pyridostigmine-induced contractions were almost completely inhibited by Y-27632 and fasudil at 30 μM for each, while acetylcholine-induced contraction was inhibited incompletely, i.e., by 56% by Y-27632 and by 51% by fasudil, at 100 μM for each, respectively. The inhibitory effects of fasudil on neostigmine- and acetylcholine-induced contractions were completely reversed by calyculin-A, a myosin phosphatase inhibitor. Neostigmine-induced IP1 accumulation was attenuated by fasudil at 100 μM. The results suggest that anti-ChEs cause airway smooth muscle contraction in part through activation of the Rho-kinase pathway.
本研究旨在确定 Rho 激酶抑制剂 Y-27632 和法舒地尔对抗胆碱酯酶 (抗 ChE) 诱导的大鼠气管收缩和磷脂酰肌醇反应的影响。通过使用大鼠气管环或切片进行等长张力和形成的[^3H]肌醇单磷酸(IP_1)的体外测量。新斯的明和吡斯的明诱导的收缩几乎被 Y-27632 和法舒地尔分别在 30 μM 时完全抑制,而乙酰胆碱诱导的收缩则被不完全抑制,即分别在 100 μM 时 Y-27632 抑制了 56%,法舒地尔抑制了 51%。法舒地尔对新斯的明和乙酰胆碱诱导的收缩的抑制作用被肌球蛋白磷酸酶抑制剂花萼蛋白-A 完全逆转。 100 μM 法舒地尔可减弱新斯的明诱导的 IP1 积累。结果表明,抗 ChE 药物部分通过激活 Rho 激酶途径导致气道平滑肌收缩。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Anticholinesterase drugs stimulate smooth muscle contraction of the rat trachea through the Rho-kinase pathway.
抗胆碱酯酶药物通过 Rho 激酶途径刺激大鼠气管平滑肌收缩。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shibata O;Saito M;Yoshimura M;Yamaguchi M;Nishioka K;Makita T;Sumikawa K.
  • 通讯作者:
    Sumikawa K.
Selegiline, an MAO-B inhibitor, attenuates airway smooth muscle contraction in the rat trachea.
司来吉兰 (Selegiline) 是一种 MAO-B 抑制剂,可减弱大鼠气管中的气道平滑肌收缩。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Saito M;Shibata O;Yamaguchi M;Yoshimura M;Makita T;Niwa M;Sumikawa K.;入田和男;Yoshimura M
  • 通讯作者:
    Yoshimura M
Selegiline, an MAO-B inhibitor, attenuates airway smooth muscle contraction in the rat trachea
司来吉兰 (Selegiline) 是一种 MAO-B 抑制剂,可减弱大鼠气管中的气道平滑肌收缩
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoshimura M;Shibata O;Saito M;Yamaguchi M;Nishioka K;Makita T;Sumikawa K.
  • 通讯作者:
    Sumikawa K.
Propofol attenuates ovalbumin-induced smooth muscle contraction of the sensitized rat trachea: Inhibition of serotonergic and cholinergic signaling
  • DOI:
    10.1213/01.ane.0000229853.01875.60
  • 发表时间:
    2006-09-01
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Yamaguchi, Masakazu;Shibata, Osamu;Sumikawa, Koji
  • 通讯作者:
    Sumikawa, Koji
Metoclopramide causes airway smooth muscle relaxation through inhibition of muscarinic M3 receptor in the rat trachea
甲氧氯普胺通过抑制大鼠气管中的毒蕈碱 M3 受体而导致气道平滑肌松弛
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J.Khotib;M.Narita;M.Suzuki;Y.Yajima;T.Suzuki;Saito M
  • 通讯作者:
    Saito M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIBATA Osamu其他文献

Phase-Difference Compensation and Nonuniform Pulse Transmission for Accurate Real-Time Moving Object Tracking
用于精确实时移动物体跟踪的相位差补偿和非均匀脉冲传输

SHIBATA Osamu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIBATA Osamu', 18)}}的其他基金

Development of Innovative Targeting Hybrid Artificial Pulmonary Surfactant Preparations by Nanomedicine
纳米医学创新靶向混合人工肺表面活性剂制剂的开发
  • 批准号:
    26350534
  • 财政年份:
    2014
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Innovative Targeting Artificial pulmonary surfactant preparations by Nanomedicine
纳米医学创新靶向人工肺表面活性物质制剂的开发
  • 批准号:
    23510134
  • 财政年份:
    2011
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of contraction/relaxation of airway smooth muscle : relationship between β-antagonist and Rho-kinase pathway
气道平滑肌收缩/舒张机制:β-拮抗剂与Rho激酶途径的关系
  • 批准号:
    19591804
  • 财政年份:
    2007
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research and development of de novo-designed peptide/fluorinated carbon hybrid artificial lung surfactant
从头设计肽/氟化碳杂化人工肺表面活性剂的基础研究与开发
  • 批准号:
    17310075
  • 财政年份:
    2005
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effects of Intravenous anesthetics on Phosphatidylinositol Response of Spinal Descending Inhibitory Pathways of Rat
静脉麻醉药对大鼠脊髓下降抑制通路磷脂酰肌醇反应的影响
  • 批准号:
    10671421
  • 财政年份:
    1998
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ROLES OF PHOSPHATIDYLINOSITOL IN THE MECHANISMS INVOLVED IN THE AIRWAY SMOOTH MUSCLE RELAXATION INDUCED BY ATP-SENSITIVE POTASSIUM CHANNEL OPENERS
磷脂酰肌醇在 ATP 敏感钾通道开放剂诱导的气道平滑肌松弛机制中的作用
  • 批准号:
    08671750
  • 财政年份:
    1996
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Study on Two Dimensional Dynamic Process of Ionic Surfactants Composed of Fluorocarbon and Hydrocarbon Ions
氟碳烃离子组成的离子表面活性剂二维动态过程研究
  • 批准号:
    07672318
  • 财政年份:
    1995
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Estimation of ultraviolet radiation as a limiting factor for vertical distribution of plants by studying their ultraviolet resistance.
通过研究植物的紫外线抵抗力来估计紫外线辐射作为植物垂直分布的限制因素。
  • 批准号:
    02804054
  • 财政年份:
    1990
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

激活NF-κB/Rho-kinase 和TGF-β/Smads信号传导通路在术后腹膜粘连形成中的研究
  • 批准号:
    81570473
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
阿魏酸通过RhoA/Rho-kinase信号通道降低肝硬化门脉压力的分子机制
  • 批准号:
    81070342
  • 批准年份:
    2010
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目

相似海外基金

Defining the Rho-kinase PKN2 as a 1p22 encoded tumour suppressor in colorectal cancer.
将 Rho 激酶 PKN2 定义为结直肠癌中 1p22 编码的肿瘤抑制因子。
  • 批准号:
    MR/X018997/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Research Grant
Vascular Smooth Muscle Lysyl Oxidase Mediated Increase in Vessel Stiffness and its Effect on Rho-Kinase Mechanosensors
血管平滑肌赖氨酰氧化酶介导的血管硬度增加及其对 Rho 激酶机械传感器的影响
  • 批准号:
    10768089
  • 财政年份:
    2023
  • 资助金额:
    $ 1.79万
  • 项目类别:
Rho-kinase signaling in energy balance
能量平衡中的 Rho 激酶信号传导
  • 批准号:
    10529777
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
Role of Rho-kinase in phosphate metabolism and diabetic kidney diseases
Rho激酶在磷酸盐代谢和糖尿病肾病中的作用
  • 批准号:
    22K08347
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rho-kinase signaling in energy balance
能量平衡中的 Rho 激酶信号传导
  • 批准号:
    10659215
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
Rho-kinase活性に着目した微小血管狭心症の新規治療法及び治療戦略の確立
以Rho激酶活性为核心的微血管心绞痛新治疗方法和治疗策略的建立
  • 批准号:
    21K08096
  • 财政年份:
    2021
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The efficacy and potential mechanisms of rho-kinase inhibitor in postoperative cognitive dysfunction
rho激酶抑制剂治疗术后认知功能障碍的疗效及潜在机制
  • 批准号:
    20K09237
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of primary cilia in corneal endothelium using Rho kinase inhibitors
使用 Rho 激酶抑制剂分析角膜内皮中的初级纤毛
  • 批准号:
    20K18388
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Depolarization-induced contraction of vascular smooth muscle via novel RhoA/Rho-kinase activation.
通过新型 RhoA/Rho 激酶激活,去极化诱导血管平滑肌收缩。
  • 批准号:
    19K07108
  • 财政年份:
    2019
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical trial of prevention for PCI-related myocardial infarction evaluating index of microvascular resistance in stable coronary artery disease. -Effect of Fasudil, a selective Rho-kinase inhibitor-
稳定性冠心病微血管阻力评价指标预防PCI相关心肌梗死的临床试验
  • 批准号:
    19K08551
  • 财政年份:
    2019
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了